Clinical study to evaluate the efficacy of Samangadi Taila Pichu-dharana and Dashmooladi Taila Matra Basti in the management of Prasramsini Yonivyapad (uterine prolapse)

An exploratory clinical study to evaluate the efficacy of Samangadi Taila Pichu-dharana and Dashmooladi Taila Matra Basti in the management of Prasramsini Yonivyapad (uterine prolapse)

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/03/041123

Enrollment

Registered

2022-03-15

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N819- Female genital prolapse, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Female patients of Age group: 25-65 years 2.1st and 2nd degree uterine prolapse with or without cystocele or rectocele.

Exclusion criteria

Exclusion criteria: 1. 3rd degree prolapse and procidentia 2. Active infection in vagina 3. Pregnant women 4. Congenital anomalies 5. PID 6. Infectious, benign or malignant growth of genital organs • Carcinoma of cervix

Design outcomes

Primary

Measure	Time frame
Improvement in pelvic organ prolapse quantitative grading scale.Timepoint: 3-6 months	—

Secondary

Measure	Time frame
1. Improvement in the symptoms like dragging pain in back. 2. Improvement in quality of life (PFDI-20 and PFIQ-7) 3. Improvement in urinary symptoms, bowel symptoms and sexual symptoms.Timepoint: 3-6 months	—

Countries

India

Contacts

Public ContactAlfia Saleem

All India Institute of Ayurveda, New Delhi

sujatadkadam@gmail.com9818294577

Outcome results